RAPGEF3 and neoplasm: Other than neuropeptide-induced cAMP-mediated tumour progression, only the mechanism underlying VIP-induced tumour growth has been well studied and mediated via cAMP/EPAC/ERK/PI3K pathways in tumour cells.